RAPS

Califf ‘disappointed’ about election, warns of changes at FDA

Robert Califf, commissioner of the US Food and Drug Administration (FDA), said he is “disappointed” in the outcome of the presidential election and warned of potential changes coming to the agency ...
RAPS

Califf: Leveraging Real World Evidence is 'Top Programmatic Priority' for FDA

The "top programmatic priority" for the US Food and Drug Administration (FDA), under Commissioner Robert Califf, is to leverage real world evidence from the healthcare system to inform FDA decision ...
RAPS

Califf previews priorities if confirmed as FDA commissioner

In correspondence with two Republican senators before his nomination was advanced in the Senate last week, FDA Commissioner-nominee Robert Califf committed to promoting the use of real-world evidence ...
RAPS

This Week at FDA: Califf faces Senate Appropriations hearing, interagency biotech plan, and remanufacturing guidance

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. This week, ...
RAPS

Califf: ‘Enormous’ implications for FDA if user fee programs are not reauthorized

In a tumultuous year coinciding with the agency’s five-year user fee reauthorization cycle, US Food and Drug Administration (FDA) Commissioner Robert Califf discussed his priorities for the agency and ...
RAPS

This Week at FDA: Bracing for a shutdown, new chief of staff, Califf at CES

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...